Auriga
Auriga USA is a research and trading platform that focuses on growth sectors within the Health Care and Technology verticals. We operate out of our main office in New York City, and also have satellite offices in Boston, San Francisco, Philadelphia, San Diego, and Washington D.C. This regional network helps us to keep abreast of key corporate developments, enhance client relationships, and provide more efficient product distribution to meet clients' investment needs. The firm is committed to providing our clients with critical information flow, investment ideas, and access to industry experts.
View Older Stories View More Recent Stories
-
Auriga Maintains a 'Buy' on Cavium Networks (CAVM); Drives In-line Q2, Soft Guidance; Search Offering Positive
-
Auriga Upgrades Allscripts-Misys Healthcare (MDRX) to Buy; All Aboard Allscripts (Again!)
-
Auriga Maintains a 'Buy' on MEMC Electronic Materials (WFR); Don't Ignore Compelling Valuation
-
Auriga Reiterates a 'Buy' on eResearch Technology (ERT); A Modest Guide-Down but Year looks Intact
-
Auriga Reiterates a 'Buy' on MedAssets (MDAS); A Beat and Decent Guide Should Offset Negative Sentiment
-
Auriga Maintains a 'Buy' on Intevac (IVAC); F2Q11 Upside Pulled From 3Q
-
Auriga Reiterates a 'Buy' on McKesson (MCK); Another Strong Q: Should Only Get Better
-
Auriga maintains a 'Hold' on Computer Programs and Systems (CPSI); It's Happening! Q2 Beats by $0.18
-
Auriga maintains a 'Buy' EZchip Semiconductor (EZCH); Near Term Risk, Longer term Growth Trends Intact
-
Auriga Maintains a 'Hold' on NetLogic (NETL); Gross Margins Drive EPS Beat, But No Organic Growth
-
Auriga Reiterates a 'Buy' on Cavium Networks (CAVM); Recent Weakness Creates a Strong Buying Opportunity
-
Auriga Reiterates a 'Buy' on Omnicell (OMCL); Modest Q2 Beat: Raising Target
-
Auriga Reiterates a 'Buy' on Cerner (CERN); Strong Results, Record Q2 Bookings
-
Auriga Maintains a 'Hold' on Waters Corp. (WAT); Q2 Review: Falls Short of High Expectations; Underlying Markets Healthy
-
Auriga Reiterates a 'Buy' on Illumina (ILMN); Great Quarter and Solid Guidance Run Head on Into Even Greater Expectations
-
Auriga Maintains a 'Hold' on Juniper Networks (JNPR); Huge Miss to Test Investor's Faith
-
Auriga Maintains a 'Buy' on Broadcom (BRCM); Strong Top-line Guide, Restrained Opex and Improving Gross Margins
-
Notable Analyst Rating Changes 07/25: (CF) (MSI) (INTU) Upgraded; (KR) (PEP) (SOLR) Downgraded
-
Auriga Starts First Solar (FSLR) at Buy
-
Auriga Starts SunPower (SPWRA) at Sell
-
Auriga Starts MEMC Electronic Materials (WFR) at Buy
-
Auriga Reiterates a 'Hold' on athenahealth (ATHN); Strong Q2 Results, Guidance; Raise Target
-
Notable Analyst Rating Changes 07/22: (DF) (KLIC) (ADSK) Upgraded; (MSFT) (RT) (NYB) Downgraded
-
UPDATE - Auriga Initiates Coverage on LifePoint Hospitals (LPNT); The Economy – Limiting Life...That’s The Point
-
UPDATE - Auriga Initiates Coverage on Health Management Associates (HMA) with a Buy; The DaVinci Code; “Mako-ing” Growth
-
UPDATE - Auriga Initiates Coverage on Community Health Systems (CYH); Bid for Tenet (THC), then HHS Investigation and Tenet Lawsuit
-
Auriga Starts Community Health (CYH) at Hold
-
Auriga Starts Health Management (HMA) at Buy
-
Auriga Starts Lifepoint Holdings (LPNT) at Hold
-
Auriga Maintains a 'Buy' on Seagate Technology (STX); Valuation Attractive N-T, and Much More Attractive with Post-Merger Benefits
-
Auriga Maintains a 'Buy' on Xilinx (XLNX); Strong Beat, Inline Guide despite Gross Margin Headwinds
-
Auriga Reiterates a 'Buy' on Dell (DELL); Acquisition of Force10 Networks Fits
-
Auriga Maintains a 'Buy' on Western Digital Corp. (WDC); Bumping Up Forward Estimates and PT
-
Auriga Maintains a 'Buy' on Seagate Technology (STX); Raising Estimates as All Trends Pointing Up on Margins
-
Auriga Maintains a 'Buy' on Broadcom (BRCM); Strength in Connectivity/Ethernet Partially Offset by Nokia/STB Headwinds
-
Auriga Reiterates a 'Hold' on athenahealth (ATHN); UH Deal is Nice, but Maybe Too Much Hullabaloo
-
Auriga Maintains a 'Hold' on EMC (EMC); Raising Estimates Ahead of Expected Strong Qtr
-
Auriga Reiterates a 'Buy' on eResearch Technology (ERT); Growth at a Value Price
-
Auriga Reiterates a 'Buy' on Dell (DELL); Bullish Tone at Analyst Day Suggests Turn-Around Story on Track
-
Auriga Reiterates a 'Buy' on Medidata Solutions (MDSO); A "Clinical Force" to be Reckoned With
-
Auriga maintains a 'Hold' on NetApp (NTAP); Look for Confirmation of Share Gain Story at Analyst Day
-
Auriga Maintains a 'Hold' on Cisco (CSCO); Expecting Continued Margin and Growth Pressures
-
Auriga Maintains a 'Buy' on Dell (DELL); Expect Positive Analyst Day Next Week
-
Auriga Reiterates a 'Buy' on Seagate Technology (STX); Raising Estimates After Latest Checks Suggest Potential for Unit and Pricing Upside
-
Auriga Maintains a 'Buy' on Western Digital (WDC); Raising Estimates After Latest Checks Suggest Healthy HDD Demand
-
Auriga Upgrades Mettler-Toledo (MTD) to Buy
-
Notable Analyst Rating Changes 06/15: (NTAP) (ARUN) (FIG) Upgraded; (CPST) (MYGN) (SOL) Downgraded
-
Auriga Downgrades Myriad Genetics (MYGN) to Hold on Valuation; Delayed Gratification
-
Auriga Cuts Myriad Genetics (MYGN) to Hold
-
Auriga Maintains a 'Buy' on Intevac (IVAC); Trimming C11 Estimates After Updating Proprietary Platter Analysis

